Cagrilintide
Cagrilintide (long-acting amylin-receptor agonist peptide) · ≥98% (HPLC)
Cagrilintide is a synthetic 37-residue lipidated amylin-receptor agonist peptide supplied as a characterized reference material for in-vitro receptor and analytical research. For Research Use Only. Not for human or veterinary use.
More in Metabolic signaling
Tirzepatide
Direct-lab pricing · up to 50% below comparable retail listings
Tirzepatide is a synthetic 39-residue lipidated dual GIP/GLP-1 receptor agonist peptide supplied as a characterized reference material for in-vitro receptor and analytical research. For Research Use Only. Not for human or veterinary use.
Retatrutide
Direct-lab pricing · up to 50% below comparable retail listings
Retatrutide (LY3437943) is a synthetic 39-residue lipidated triple-agonist peptide used as a characterized reference material for in-vitro study of GIPR, GLP-1R, and GCGR signaling. For research use only.
Semaglutide
Direct-lab pricing · up to 50% below comparable retail listings
Semaglutide is a synthetic 31-residue lipidated GLP-1 receptor agonist peptide supplied as a characterized reference material for in-vitro receptor and analytical research. For Research Use Only. Not for human or veterinary use.
Research profile & documentation
- Why researchers study it
- Studied in receptor-pharmacology research as a long-acting amylin-analog probe engaging multiple amylin-receptor subtypes and the calcitonin receptor, often used alongside GLP-1 analogs in comparative co-agonism studies.
- Mechanism themes in research
- Amylin receptor (AMY1R/AMY2R/AMY3R) and calcitonin receptor (CTR) agonismPramlintide-backbone structure-activity substitutions (N14E, V17R, P37Y)C20 fatty-diacid lipidation enabling albumin association studied in PK/structural contextsComparative amylin/incretin co-agonism pharmacology
- What the evidence does not establish
- Published references are in-vitro or pre-clinical and describe research context only. They do not establish safety, efficacy, or any outcome in humans or animals, and Get Peptides makes no such claims.
- Quality markers
- ≥98% (HPLC)MS identityLot COACold-chain
- What ships
- The sealed lot-controlled vial, a measured ampoule of bacteriostatic water, and a printed handling & reconstitution card — plus the per-lot COA. Everything to prepare it, in one box.
Cagrilintide is a synthetic, lipidated amylin-analog peptide supplied as a characterized reference material for receptor pharmacology, peptide chemistry, and comparative amylin/incretin research. This page explains the structural and assay context without turning preclinical literature into human-use claims.
Molecular architecture
Cagrilintide is described as a 37-residue amylin analog with sequence substitutions and an N-terminal fatty-diacid modification connected through a linker. The catalog record reports an approximate molecular formula of C₁₉₄H₃₁₂N₅₄O₅₉S₂ and a molecular weight near 4409 g/mol. Because lipidated peptides can be reported with different conventions, the lot COA remains the controlling document for identity and purity.
Receptor research
Amylin analogs are studied across amylin-receptor complexes that combine calcitonin-receptor or related receptor components. Cagrilintide is therefore relevant to binding, receptor activation, second-messenger, internalization, and comparative ligand assays. Researchers should specify receptor composition and expression system: a result from one receptor complex cannot automatically be transferred to another.
| Full name | Cagrilintide (long-acting amylin-receptor agonist peptide) |
| Research theme | Metabolic signaling |
| CAS number | 1415456-99-3 |
| Molecular formula | C₁₉₄H₃₁₂N₅₄O₅₉S₂ |
| Molecular weight | 4409 g/mol |
| Purity | ≥98% (HPLC) |
| Physical form | Lyophilized powder |
| Storage | −20 °C, desiccated, protected from light |
Sequence
Reported research areas
- Amylin receptor (AMY1R/AMY2R/AMY3R) and calcitonin receptor (CTR) agonism assays
- Peptide lipidation and structure-activity studies
- Comparative amylin/incretin co-agonism pharmacology
- Analytical method development and reference standardization
Credible sources
- PubChem — Cagrilintide
- PubMed — cagrilintide amylin-receptor literature
- PubMed — amylin receptor pharmacology
COA with every lot
Each Cagrilintide lot is characterized by reversed-phase HPLC for purity and by mass spectrometry for identity, then documented in a per-lot Certificate of Analysis. Unique lot numbers tie the vial back to its synthesis batch and analytical data.
- RP-HPLC purity result (≥98% (HPLC))
- Mass-spectrometry identity confirmation
- Appearance, molecular weight, and storage
- Lot number and testing status
Specimen Certificate of Analysis
| Product | Cagrilintide (reference) |
| Lot | HXR-2406-111 |
| Purity (RP-HPLC) | 98%+ |
| Identity (MS) | Confirmed · 4409 g/mol |
| Appearance | Lyophilized powder |
| Storage | −20 °C, desiccated |
Representative document. Each lot has its own COA — these are quality documents, not medical claims.
Loading verified reviews…
Reviews come only from buyers we can match to a real order, and each is moderated before it appears. We never publish fabricated or incentivized reviews.